transmiss
gastroenter
viru
tgev
belong
famili
coronavirida
one
import
caus
agent
enter
infect
pig
infect
associ
high
morbid
anim
age
high
mortal
rate
seroneg
suckl
piglet
tgev
envelop
viru
positivestrand
rna
genom
approxim
size
consist
four
structur
protein
spike
integr
membran
glycoprotein
nucleocapsid
n
protein
twothird
entir
rna
end
compris
open
read
frame
encod
number
nonstructur
protein
includ
replicas
third
genom
contain
gene
encod
structur
nonstructur
protein
glycoprotein
primarili
respons
induc
neutral
antibodi
initi
infect
appear
porcin
respiratori
coronaviru
prcov
respiratori
mutant
tgev
drastic
decreas
risk
tge
europ
sinc
neutral
antibodi
elicit
avirul
prcov
provid
crossprotect
tgev
infect
contrast
tge
preval
still
report
tgev
isol
differ
part
world
eg
variou
geograph
locat
china
impli
tgev
infect
still
threaten
pig
industri
present
sever
commerci
avail
vaccin
commonli
use
prevent
tgev
infect
china
howev
current
tradit
inactiv
attenu
vaccin
less
effect
desir
due
failur
vaccin
prevent
viral
shed
revers
attenu
virul
phenotyp
lack
therapeut
treatment
tge
underlin
import
develop
effect
antivir
lithium
salt
use
treat
diseas
gout
rheumat
gout
bright
diseas
epilepsi
syphili
acut
mania
depress
episod
sever
report
regard
inhibitori
effect
lithium
salt
replic
sever
dna
virus
type
herp
simplex
viru
vaccinia
viru
recent
anoth
research
group
demonstr
lithium
chlorid
licl
inhibit
infect
cell
cultur
infecti
bronchiti
coronaviru
ibv
avian
coronaviru
purpos
current
studi
investig
action
mechan
concern
inhibitori
effect
licl
cell
infect
tgev
find
whether
suscept
licl
treatment
also
featur
rna
virus
effect
licl
tgev
infect
analyz
plaqu
assay
rtpcr
quantit
realtim
pcr
effect
drug
infect
cycl
tgev
viru
product
assess
timedepend
drug
addit
inhibit
licl
cell
apoptosi
caus
tgev
demonstr
immunofluoresc
flow
cytometri
protect
effect
licl
rna
virus
also
compar
data
demonstr
licl
may
potent
antivir
agent
via
antiapoptot
mechan
swine
testi
st
cell
porcin
kidney
cell
maintain
eagl
minimum
essenti
medium
emem
monkey
kidney
cell
line
vero
cell
cultur
dulbecco
modifi
eagl
medium
dmem
cell
purchas
atcc
kept
laboratori
cell
cultur
respect
medium
supplement
newborn
bovin
serum
nb
excel
bio
china
incub
tgev
strain
propag
st
cell
porcin
epidem
diarrhea
viru
pedv
isol
hljbi
bovin
rotaviru
brv
strain
ncdv
propag
vero
cell
cell
respect
cytotox
effect
lithium
chlorid
licl
sigma
usa
cell
viabil
analyz
trypan
blue
stain
previous
describ
briefli
cell
plate
incub
licl
serial
dilut
serumfre
emem
wellseach
dilut
h
phosphat
buffer
salin
pb
wash
cell
incub
wv
trypan
blue
mix
dilut
pb
room
temperatur
min
follow
three
time
wash
pb
percentag
viabl
cell
calcul
accord
equat
number
unstain
cellstot
number
cell
percentag
viabl
cell
effect
licl
cell
prolifer
determin
dimethylthiahiazo
mtt
assay
briefli
cell
cultur
plate
wash
three
time
pb
incub
licl
serial
dilut
serumfre
emem
wellseach
dilut
h
mocktreat
cell
serv
control
wash
pb
cell
incub
medium
mtt
solut
h
cell
incub
dimethyl
sulfoxid
dmso
tray
shaken
gentli
min
wash
pb
optic
densiti
od
valu
well
test
wavelength
nm
measur
use
elisa
reader
cell
surviv
rate
determin
drug
averag
od
valuecontrol
averag
od
valu
cytostat
concentr
defin
concentr
inhibit
prolifer
exponenti
grow
cell
non
cytotox
concentr
licl
use
antivir
assay
viru
titrat
infect
analysi
plaqu
assay
perform
previous
describ
modif
briefli
cell
seed
onto
cultur
plate
inocul
serial
dilut
virus
inoculum
replac
wv
methylcellulos
emem
mlwell
viru
absorpt
h
fortyeight
hour
later
overlaid
medium
remov
cell
rins
three
time
pb
fix
formalin
pb
min
room
temperatur
follow
stain
crystal
violet
wv
dilut
ethanol
pb
min
plaqu
number
record
complet
wash
pb
viru
titer
plaqueform
unit
pfu
calcul
infect
assay
perform
cultur
plate
unless
otherwis
indic
assay
perform
triplic
analyz
effect
licl
virus
tgev
pfuml
incub
serial
dilut
licl
medium
h
virus
moi
multipl
infect
use
infect
cell
plate
h
wash
three
time
pb
cell
overlaid
methylcellulos
medium
cultur
h
prior
plaqu
assay
analyz
impact
licl
cell
cell
plate
treat
serial
dilut
licl
medium
h
cell
infect
tgev
moi
cell
wash
pb
three
time
subsequ
cell
overlaid
methycellulos
plaqu
assay
investig
effect
licl
tgevinfect
cell
cell
plate
wash
pb
three
time
infect
tgev
moi
h
thereaft
cell
wash
pb
incub
serial
dilut
drug
h
infect
virus
calcul
plaqu
assay
analyz
effect
licl
prolifer
cell
infect
tgev
mtt
colorimetr
assay
perform
briefli
cell
plate
triplic
plate
cell
incub
tgev
moi
h
wash
pb
cell
incub
licl
differ
concentr
virusinfect
mocktreat
cell
infect
blank
control
respect
h
postinfect
hpi
cell
incub
mtt
solut
mgml
pb
h
wash
pb
cell
incub
dmso
valu
read
describ
rel
amount
surviv
cell
calcul
follow
percent
viabl
cell
od
drug
treatment
groupod
infect
control
od
blank
controlod
infect
control
revers
transcript
rt
pcr
use
amplifi
partial
gene
design
sad
encod
major
antigen
site
end
half
tgev
gene
ii
partial
gene
compris
gene
interven
sequenc
gene
design
sx
iii
nonstructur
gene
encod
housekeep
gene
betaactin
use
intern
refer
inform
regard
primer
sequenc
amplif
product
summar
tabl
tgevinfect
st
cell
treat
licl
plate
subject
rna
extract
commerci
kit
qiagen
germani
subsequ
rtpcr
perform
use
rtpcr
kit
takara
japan
pcr
profil
amplif
sad
gene
includ
min
cycl
l
min
min
l
min
final
extens
min
pcr
amplif
tgev
sx
gene
proteas
gene
betaactin
perform
describ
sad
gene
except
anneal
temperatur
respect
pcr
product
electrophores
agaros
gel
effect
licl
cell
infect
tgev
confirm
realtim
pcr
target
sx
gene
gene
tgev
st
cell
plate
infect
tgev
moi
h
cell
treat
licl
differ
concentr
h
wash
pb
viruscontain
cultur
frozen
thaw
three
time
follow
addit
equal
volum
polyethylen
glycol
pge
room
temperatur
min
sampl
centrifug
rpm
min
pellet
resuspend
rnasefre
water
total
rna
extract
commerci
kit
fastgen
china
accord
manufactur
instruct
revers
transcript
perform
total
volum
consist
cdna
oligo
dt
primer
dntp
mm
rnase
inhibitor
steril
water
mlv
buffer
reaction
perform
min
min
min
subsequ
realtim
pcr
perform
use
abi
prism
realtim
pcr
machin
appli
biosystem
usa
realtim
pcr
includ
cdna
templat
sybr
taq
polymeras
rox
pge
sens
primer
antisens
primer
steril
water
pcr
paramet
includ
cycl
express
level
tgev
sx
tgev
normal
betaactin
accord
compar
cycl
threshold
ct
method
use
quantif
recommend
manufactur
protocol
delta
ct
measur
express
tgev
sx
tgevinfect
st
cell
normal
betaactin
taken
compar
express
drug
treatment
data
analysi
base
measur
cycl
threshold
ct
isol
total
dna
untreat
sampl
taken
refer
treat
sampl
differ
ct
sampl
fragment
mean
ct
valuebetaactin
fragment
mean
ct
valu
use
measur
rel
fragment
method
correl
amplif
size
tgev
sx
tgev
fragment
brief
quantif
respect
fragment
treat
sampl
realtim
pcr
analysi
correspond
betaactin
fragment
perform
experiment
condit
realtim
pcr
conduct
quadrupl
result
averag
ct
valu
tgev
xs
tgev
fragment
use
evalu
viru
quantiti
therefor
differ
untreat
versu
treat
condit
respect
tgev
xs
tgev
fragment
calcul
method
express
ratio
reduct
fragment
experi
perform
triplic
timeofaddit
effect
licl
tgev
infect
perform
analyz
mode
action
cell
plate
infect
tgev
moi
cell
incub
licl
concentr
mm
h
interv
start
h
post
infect
hpi
infect
virus
analyz
indic
time
point
use
mtt
assay
measur
valu
well
parallel
anazly
effect
licl
viru
product
cell
infect
tgev
moi
h
follow
incub
serial
dilut
licl
subsequ
supernat
infect
cell
collect
indic
time
point
subject
plaqu
assay
pedv
brv
use
infect
vero
cell
plate
h
cultur
kept
h
presenc
licl
differ
concentr
infect
virus
determin
plaqu
assay
assay
perform
triplic
cell
apoptosi
analyz
annexin
vfitc
kit
nanj
keygen
biotech
china
previous
describ
briefli
virusinfect
cell
treat
licl
h
apoptot
cell
determin
fluoresc
microscopi
leica
germani
number
posit
cell
calcul
select
five
view
field
effect
licl
express
virusinfect
cell
analyz
use
immunofluoresc
cell
plate
infect
tgev
h
cell
incub
mm
licl
three
time
wash
pb
cell
fix
formalin
pb
follow
quench
glycin
pb
cell
incub
specif
rabbit
antibodi
beij
biosynthesi
china
h
follow
incub
fluorescein
isothiocyan
fitc
conjug
goat
antirabbit
igg
zhongshan
china
h
dark
antibodi
dilut
bsa
nuclei
stain
propidium
iodid
pi
min
dark
prior
microscop
observ
parallel
flow
cytometri
use
analyz
cell
apoptosi
abovement
cell
sampl
trypsin
centrifug
rpm
min
cell
resuspend
bind
buffer
concentr
cellsml
wash
two
time
pb
rpm
min
fitcconjug
annexinv
pi
ad
cell
incub
room
temperatur
min
dark
sampl
analyz
within
h
poststain
inhibitori
effect
licl
cell
apoptosi
compar
analyz
caspas
inhibitor
pyrrolidin
dithiocarbam
pdtc
thiol
reduc
agent
sigma
beij
briefli
st
cell
plate
treat
alon
pdtc
licl
mm
h
mock
treat
cell
use
control
analyz
inhibitori
effect
pdtc
licl
tgev
induc
cell
apoptosi
st
cell
plate
infect
tgev
alon
tgevpdtc
tgevlicl
h
mockinfect
cell
use
control
titer
tgev
appli
moi
final
concentr
pdtc
licl
mm
respect
mocktreat
cell
use
control
cell
stain
annexin
v
pi
subject
immunofluoresc
analysi
stain
trypan
blue
show
licl
nontox
concentr
mm
viabil
rate
two
cell
line
analyz
st
pk
cell
morpholog
differ
observ
drugtreat
mocktreat
cell
concentr
figur
mtt
assay
determin
activ
mitochondri
enzym
commonli
use
determin
prolif
activ
cell
show
prolifer
st
pk
cell
affect
licl
concentr
mm
data
shown
determin
whether
pretreat
either
cell
viru
affect
viral
infect
cell
tgev
inoculum
treat
concentr
mm
licl
prior
infect
subsequ
infect
either
licltreat
cell
untreat
viru
untreat
cell
licltreat
viru
indic
inhibitori
effect
regardless
whether
infect
analyz
plaqu
mtt
assay
data
shown
timeofaddit
effect
licl
infect
cycl
tgev
analyz
result
show
inhibit
rate
observ
drug
ad
within
first
h
pi
figur
shown
figur
extent
inhibit
differ
concentr
licl
whether
viru
product
assay
hpi
even
hpi
inhibitori
effect
drug
tgevinfect
cell
still
observ
protect
effect
licl
tgev
infect
confirm
rna
level
convent
rtpcr
amplif
sad
encod
major
antigen
site
gene
sx
partial
tgev
gene
togeth
partial
gene
includ
interven
sequenc
gene
gene
nonstructur
analysi
tgevrna
indic
densiti
product
band
decreas
increas
concentr
licl
data
shown
effect
licl
level
viru
rna
quantifi
realtim
rtpcr
result
demonstr
dosedepend
decreas
amount
viral
rna
synthes
tgevinfect
cell
major
reduct
rel
amplif
tgev
sx
gene
observ
cell
treat
concentr
mm
licl
figur
test
whether
licl
also
affect
rna
virus
differ
concentr
licl
analyz
effect
infect
pedv
anoth
coronaviru
bovin
rotaviru
brv
former
viru
analyz
vero
cell
figur
latter
viru
cell
figur
maximum
nontox
concentr
licl
cell
mm
mm
respect
unpublish
data
concentr
infect
inhibit
figur
apoptosi
characterist
featur
tgevinfect
cell
therefor
interest
whether
licl
abl
prevent
apoptot
effect
tgev
apoptot
cell
visual
stain
annexin
shown
figur
count
apoptot
cell
hpi
reveal
licl
decreas
tgevinduc
apoptosi
dosedepend
manner
quantif
apoptot
cell
perform
flow
cytometri
result
show
hpi
earli
apoptosi
tgevinfect
cell
significantli
decreas
treatment
mm
licl
hpi
cell
stage
late
apoptosi
also
inhibit
drug
treatment
figur
enzym
involv
apoptosi
cell
interest
know
whether
antiapoptot
effect
licl
may
explain
inhibit
shown
figur
immunofluoresc
microscopi
express
induc
tgevinfect
cell
drastic
reduc
cell
treat
licl
like
pdtc
licl
potent
apoptosi
inhibitor
term
inhibitori
effect
cell
apoptosi
induc
figur
agent
also
decreas
number
apoptot
cell
induc
tgev
effect
figur
tgev
import
pathogen
pig
caus
high
mortal
piglet
gener
siga
colostrum
sow
vaccin
virul
attenu
vaccin
provid
effect
protect
suckl
piglet
howev
potenti
dissemin
preval
infecti
agent
piglet
remain
addit
enhanc
vaccin
safeti
efficaci
develop
potenti
antivir
complementari
approach
futur
strategi
prevent
tgev
infect
limit
report
concern
antitgev
drug
lack
effect
therapeut
treatment
highlight
import
identifi
appropri
antivir
recent
yang
et
al
use
biochem
virolog
method
screen
smallmolecul
compound
inhibit
tgev
replic
author
found
seri
benzothiazolium
compound
inhibitori
activ
tgev
one
main
proteas
replicas
polyprotein
coronavirus
drug
exert
antitgev
activ
term
viral
protein
synthesi
rna
replic
tgevinfect
st
cell
recent
licl
found
effect
prevent
infect
ibv
avian
coronaviru
vitro
find
regard
inhibitori
effect
licl
ibv
novel
inhibitori
effect
report
previous
sever
dna
virus
see
whether
coronavirus
differ
speci
gener
suscept
licl
treatment
perform
evalu
antivir
effect
licl
tgev
porcin
coronaviru
first
use
two
approach
analyz
tgev
infect
two
cell
line
porcin
kidney
cell
line
swine
testi
cell
line
st
inhibitori
effect
licl
evid
viru
titrat
plaqu
assay
viabil
cell
determin
mtt
assay
quantifi
mitochondri
dehydrogenas
activ
addit
tgev
strain
virul
tgev
isol
hbi
test
sensit
licl
found
also
affect
inhibitor
data
shown
time
infect
differ
cell
line
pedv
anoth
porcin
coronaviru
bovin
rotaviru
prv
doublestrand
rna
viru
inhibit
licl
effect
data
show
inhibit
licl
may
gener
featur
viru
famili
eg
coronavirus
addit
found
licl
directli
interact
inactiv
tgev
particl
ineffect
preincub
host
cell
contrast
inhibit
plaqu
format
virusinfect
cell
result
consist
inhibitori
effect
licl
ibv
therefor
confirm
hypothesi
sensit
coronaviru
licl
gener
featur
viru
famili
suggest
licl
may
act
inhibitor
dna
viru
herp
simplex
viru
viral
proteas
play
key
role
viru
replic
identifi
potenti
target
search
antivir
agent
eg
treatment
human
immunodefici
viru
hepat
c
viru
infect
studi
convent
rtpcr
target
leader
sequenc
gene
conjunct
partial
tgev
gene
indic
effect
licl
could
rna
transcript
replic
ibv
tgev
coronavirus
also
possibl
licl
inhibit
rnadepend
rna
polymeras
characterist
posit
negativestrand
rna
virus
address
action
licl
tgev
replic
plaqu
format
viru
product
quantifi
use
timeofaddit
assay
infect
cycl
tgev
result
show
licl
inhibit
tgev
infect
effect
ad
late
h
viru
inocul
indic
inhibit
licl
occur
whole
viral
replic
infect
studi
use
differ
tgev
titer
cell
infect
inhibit
tgev
licl
vitro
titerindepend
impli
drug
also
inhibit
viru
spread
cell
cell
impact
licl
tgev
load
evalu
realtim
pcr
confirm
inhibit
activ
tgev
recent
antivir
activ
quercetin
pedv
anoth
porcin
coronaviru
analyz
interestingli
effect
tgev
prcv
respiratori
variant
tgev
lower
compar
pedv
find
might
suggest
coronavirus
differ
suscept
drug
studi
show
coronavirus
tgev
pedv
equal
sensit
licl
treatment
brv
anoth
rna
viru
show
similar
sensit
inhibitor
find
suggest
consist
sensit
coronavirus
rna
virus
licl
tgev
first
coronaviru
document
trigger
apoptosi
infect
cell
subsequ
infecti
bronchiti
viru
ibv
murin
hepat
viru
mhv
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
equin
coronaviru
found
similar
apoptot
effect
studi
confirm
tgev
infect
induc
appear
apoptot
cell
shown
immmunofluoresc
analysi
flow
cytometri
result
show
apoptot
cell
stage
late
apoptosi
h
postinfect
howev
earli
late
apoptosi
tgevinfect
cell
inhibit
licl
effici
member
aspartatespecif
cysteinyl
proteas
caspas
identifi
key
mediat
apoptosi
mammalian
cell
studi
express
inhibit
addit
licl
tgevinfect
cell
pdtc
known
caspas
inhibitor
abl
inhibit
tgev
induc
apoptosi
interestingli
found
licl
also
potent
inhibitori
effect
tgevinduc
cell
apoptosi
apoptosisassoci
caspas
activ
tgev
sarscov
report
therefor
anticip
licl
may
protect
effect
sarscov
induc
infect
apoptosi
taken
togeth
data
indic
licl
may
inhibit
tgev
infect
via
exert
antiapoptot
effect
mediat
caspas
pathway
